Neoadjuvant Targeted Therapy for Resectable ALK-fusion Locally Advanced Non-small Cell Lung Cancer

被引：0
|
作者：
Zhao, D. [1 ]
Wu, N. [1 ]
机构：
[1] Peking Univ Canc Hosp & Inst, Beijing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Neoadjuvant; Targeted therapy; ALK-fusion;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-02
引用
收藏
页码：S295 / S296
页数：2
相关论文
共 50 条
  • [41] IMPACT OF NEOADJUVANT THERAPY ON TUMOR RESECTABILITY AND SURVIVAL OF PATIENTS WITH LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER
    Aso Gonzalez, Samantha
    Pascual Cascon, Raquel
    Munoz Esquerre, Mariana
    Martinez Ballarin, Jose Ignacio
    Padrones, Susana
    Macia Vidueira, Ivan
    Rivas Doyague, Francisco
    Cardenal, Felipe
    Arnaiz Fernandez, Maria Dolores
    Morchon Ramos, Sergio
    Dorca, Jordi
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1585 - S1585
  • [42] Neoadjuvant Therapy in Non-Small Cell Lung Cancer
    Zheng, Yifan
    Jaklitsch, Michael T.
    Bueno, Raphael
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 25 (03) : 567 - +
  • [43] Neoadjuvant therapy in non-small cell lung cancer
    Grant, Christopher
    Hagopian, Garo
    Nagasaka, Misako
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 190
  • [44] Neoadjuvant therapy for non-small cell lung cancer
    Gandara, DR
    Lara, PN
    Goldberg, Z
    Roberts, P
    Lau, DHM
    ANTI-CANCER DRUGS, 2001, 12 : S5 - S9
  • [45] The therapy of locally advanced non-small cell lung cancer (NSCLC) in the elderly
    Schild, S. E.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 60 : S7 - S7
  • [46] Optimized local therapy for locally advanced non-small cell lung cancer
    Billiet, Charlotte
    De Ruysscher, Dirk
    JOURNAL OF THORACIC DISEASE, 2017, 9 (07) : 1783 - 1785
  • [47] Evaluation of neoadjuvant "window of opportunity" trials with targeted therapy in patients with surgically resectable non-small cell lung cancer.
    Stiles, B. M.
    Mirza, F.
    Chiu, Y.
    Port, J. L.
    Lee, P. C.
    Paul, S.
    Altorki, N. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [48] Neoadjuvant targeted therapy for resectable EGFR-mutant non-small cell lung cancer: Current status and future considerations
    Liu, Wenliang
    Ren, Siying
    Xiao, Ying
    Yang, Lulu
    Zeng, Chao
    Hu, Yan
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [49] Emerging role of targeted therapy in the management of locally advanced (LA) non-small cell lung cancer (NSCLC)
    Langer, CJ
    LUNG CANCER, 2004, 46 : S28 - S30
  • [50] The Evolving Role of Targeted Therapy in Early-Stage and Locally Advanced Non-small Cell Lung Cancer
    West, Howard
    CURRENT ONCOLOGY REPORTS, 2011, 13 (04) : 280 - 289
12345